Evotec SE American Depositary Shares (EVO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Evotec SE American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.60
+2.23% today
Market cap
$559M
Overall quality
31/100
Kronos AI 30-day
+28.5%
8 of 8 simulated paths end higher
Evotec SE American Depositary Shares (EVO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $559M. It trades at $1.60, up 2.23% today. Its overall quality score is 31 out of 100, ranked against the whole US market. 1 analysts' average target of $4.00 implies +150.0% from today's price. Kronos AI's 30-day forecast is +28.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $4.00 |
| Low – high | $4.00 – $4.00 |
| Analysts | 1 |
| Upside to average | +150.0% |
Kronos AI 30-day forecast
| Expected close | $2.02 (+28.5%) |
| Likely range | +22.0% … +32.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 22 |
| Solvency | 35 |
| Growth | 37 |
| Overall | 31 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.